Atlas Trials

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Clinical trial NCT00282581 · TERMINATED

Trial details

NCT number
NCT00282581
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV InfectionsSmallpox
Start date
2006-10-01
Primary completion
2007-07-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.